Self-management of anticoagulation

Marcel Levi1

  • 1Department of Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. m.m.levi@amc.uva.nl

Insights

Patients managing their own warfarin anticoagulation using portable INR devices achieve better therapeutic control and improved quality of life compared to standard care. This self-management approach enhances patient satisfaction and clinical outcomes.

Area of Science:

  • Cardiology
  • Hematology
  • Patient Self-Management

Background:

  • Vitamin K antagonist therapy, such as warfarin, necessitates frequent International Normalized Ratio (INR) monitoring and dose adjustments.
  • Suboptimal anticoagulation control (30-50% of the time) and time-consuming clinic visits negatively impact patient satisfaction.

Purpose of the Study:

  • To evaluate the efficacy and patient-reported outcomes of self-management of anticoagulation using portable coagulometers.
  • To compare self-management with traditional care models provided by general practitioners, specialists, and specialized anticoagulation clinics.

Main Methods:

  • Utilized portable coagulometers for self-measurement of INR from capillary blood.
  • Patients self-adjusted warfarin dosage based on INR readings.
  • Compared outcomes with standard anticoagulation management strategies.

Main Results:

  • Self-management of INR and warfarin dosing led to superior anticoagulation control compared to general practitioner or specialist care.
  • Anticoagulation control in self-managing patients was comparable to that achieved in specialized anticoagulation clinics.
  • Patients engaged in self-management reported significant improvements in treatment satisfaction and quality of life.

Conclusions:

  • Portable coagulometers empower patients to effectively self-manage warfarin therapy.
  • Anticoagulation self-management offers a viable and beneficial alternative to traditional care, improving both clinical control and patient well-being.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...